Laboratory Investigations of Macrocytic Anemia

Hemolysis Markers (LDH, Haptoglobin, Indirect Bilirubin)

Macrocytic anemia is a condition characterized by enlarged red blood cells. Evaluating hemolysis markers, such as LDH, haptoglobin, and indirect bilirubin, aids in diagnosing underlying causes.

6/7/20254 min read68 views
loved it
normalintermediatePathology
Laboratory Investigations of Macrocytic Anemia: Hemolysis Markers

Laboratory Investigations of Macrocytic Anemia

Understanding Hemolysis Markers

Macrocytic anemia is characterized by larger-than-normal red blood cells, often indicative of underlying hematological disorders. One crucial aspect of its diagnosis involves assessing hemolysis markers, including lactate dehydrogenase (LDH), haptoglobin, and indirect bilirubin.

Key Hemolysis Markers

Lactate Dehydrogenase (LDH)

LDH is an intracellular enzyme that plays a role in energy metabolism. Elevated LDH levels suggest increased red cell turnover, often seen in hemolysis.

Haptoglobin

Haptoglobin binds free hemoglobin released during red cell destruction. Low serum haptoglobin levels indicate ongoing hemolysis.

Indirect Bilirubin

Indirect bilirubin forms when hemoglobin breaks down. Increased levels signal excessive red blood cell destruction, aiding in macrocytic anemia diagnosis.

Diagnostic Significance

Evaluating these markers provides insight into the etiology of macrocytic anemia, distinguishing between hemolytic and non-hemolytic causes.

Tags

#Macrocytic anemia#LDH#Haptoglobin#Indirect bilirubin#Hemolysis markers#Pathology

0 people loved it

Recommended Reads

Explore related articles that might interest you

Diagnostic Evaluation of Anemia Based on Presumed Etiology
32
13%

Diagnostic Evaluation of Anemia Based on Presumed Etiology

Read more →
32
Appropriate diagnostic workup based on the presumed etiology of anemia
36
12%

Appropriate diagnostic workup based on the presumed etiology of anemia

Read more →
36
Definition and Classification of Anemia
6
12%

Definition and Classification of Anemia

Read more →
6
Etiopathogenesis, clinical features, and management of Vitamin B12 and Folate deficiency anemia
46
12%

Etiopathogenesis, clinical features, and management of Vitamin B12 and Folate deficiency anemia

Read more →
46
Definition, classification, and morphological characteristics of anemia
33
12%

Definition, classification, and morphological characteristics of anemia

Read more →
33
Mediastinal Diseases
25
11%

Mediastinal Diseases

Read more →
25
Classification and Staging of Cancer (AJCC, FIGO, TNM, etc.)
16
11%

Classification and Staging of Cancer (AJCC, FIGO, TNM, etc.)

Read more →
16
© 2025 MedGloss. All rights reserved.